Table 2.
Basal characteristics and embryo X chromosome abnormality rate in TS and control group
| TS n=100 | Control n=136 | P value | |
|---|---|---|---|
| Age | 35.41±5.84 | 35.8±5.54 | NS |
| Infertile years | 4.61±4.16 | 4.13±3.85 | NS |
| BMI (kg/m2) | 22.63±2.66 | 22.05±2.14 | NS |
| 45,X mosaic rate | 0.17±0.26 | 0 | |
| AFC | 13.54±9.47 | 15.25±10.48 | NS |
| AMH(ng/ml) | 3.23±3.37 | 3.64±3.30 | NS |
| Treatment protocol | |||
| GnRH agonist | 25 | 64 | <0.05 |
| GnRH antagonist | 66 | 67 | |
| Other | 9 | 5 | |
| Cancel rate | 43% (43/100) | 42.65% (58/136) | NS |
| X chromosome aneuploid rate | 7.04% (15/213) | 1.61% (4/249) | <0.01 |
NS, not significantly different; BMI, body mass index; AFC, antral follicle count